Steven King was appointed President of Avid Bioservices in 2001. In his capacity as president of Avid, he was given the responsibility in 2001 to transform Peregrine Pharmaceuticals in-house dedicated manufacturing facility into a multi-product biologics contract manufacturing organization. He has continued serving as President of Avid since its inception and also serves as president and CEO of Peregrine Pharmacteuticals. Steven's background is in research and development of biologics and he is a co-inventor on over 25 U.S. and foreign patents and patent applications. He holds BS and MS degrees in Biology from Texas Tech University.

Paul Lytle has served as Chief Financial Officer since August 2002. Mr. Lytle oversees Finance & Accounting, SEC Reporting, Investor Relations, Human Resources and Information Technology. Mr. Lytle started with Peregrine, the parent company of Avid, in March 1997 as Corporate Controller and has held positions of increasing responsibility at the company. Mr. Lytle has been responsible for the development and implementation of numerous technology initiatives, increasing the company's efficiency in many areas, including finance. During his tenure, Peregrine has raised over $100 million in equity financing from the public markets. Prior to joining Peregrine, Mr. Lytle worked for Deloitte & Touche LLP. Mr. Lytle holds a BS in Business Administration from the California State University at Long Beach and is a certified public accountant in the State of California and a member of the American Institute of Certified Public Accountants.

Truc Le joined Avid Bioservices, Inc. as Chief Operating Officer in July 2009. Mr. Le has over 30 years of extensive experience in the field of Worldwide Operations, Quality Systems Management, and Business Effectiveness. Prior to joining Avid Bioservices, Mr. Le was Senior V.P. of Operations and Corporate Quality for Nektar Therapeutics, a biopharmaceutical company. His responsibilities included manufacturing, supply chain, materials, purchasing, facility, ERP implementation, quality management, and compliance. Prior to joining Nektar, Mr. Le was employed by a division of Johnson & Johnson for 20 years as the Worldwide Vice-President of Regulatory Compliance and Quality Systems and a member of Executive Management. Mr. Le is also a co-founder of a consulting firm, MLH Group, specializing in Global Operations, Regulatory Affairs, Quality Management, and Business Excellence for Pharmaceutical, Biotechnology, Medical Device, In Vitro Diagnostics (IVD) industry as well as drug/device combination products. Mr. Le has been assisting numerous companies ranging from start-up to Fortune 100 corporations in developing their Operations and Regulatory Affairs that meet U.S. FDA and International Standards, including achievements of ISO registration and CE mark approval for European Union. He has also assisted companies in Business Excellence utilizing Six Sigma techniques improving operational efficiency and effectiveness. Mr. Le has a BS in mechanical engineering, MBA in Management, and completed numerous executive leadership training programs, including World Class Manufacturing at Duke University, Executive Management at Harvard University, and a QSR trainer at AAMI/FDA.

Richard Richieri was appointed VP of manufacturing in October of 2001. Richard has over ten years of experience in the biologics industry manufacturing proteins and antibodies. At Peregrine, as director of manufacturing, Richard was responsible for process development and manufacture of clinical trial materials. At Avid Bioservices, Richard is responsible for all manufacturing including process development and facilities. Prior to joining Peregrine, Richard worked at Xoma Corporation where he was responsible for large-scale manufacturing and mammalian cell culture process development utilizing Xoma's CHO cell line. Richard received his M.S. from University of California, San Diego (UCSD) studying the dependency of antibody production on cell cycle kinetics. He received his Bachelor's degree from University of California, Los Angeles (UCLA) in Chemical Engineering. Mr. Richieri is licensed as an Exemptee Pharmacist by the Board of Pharmacy State of California.

Chris Eso joined Avid Bioservices, Inc. as Vice President of Business Operations in January 2009. Mr. Eso has over 12 years of business experience, primarily in the pharmaceutical and life sciences industries, including corporate development, strategic planning, project management, investor relations and public relations. He has extensive transaction experience including structuring, negotiating and completing various strategic transactions, on a global basis. Mr. Eso was formerly employed with Agilent Technologies, Inc. where he served as Manager of Corporate Development, responsible for executing strategic transactions across all businesses, ranging from mergers and acquisitions, partnerships and alliances, joint ventures, product and technology in-licensing, minority and equity investments, and divestitures. Prior to joining Agilent, Mr. Eso was previously with Peregrine Pharmaceuticals, Inc., parent company of Avid Bioservices, Inc., as Director of Corporate Development from August 2007 to February 2008, where he was instrumental in achieving the first Wall Street security analyst coverage for the Company, as well as leading potential partnering discussions and strategic transactions. Mr. Eso was formerly employed with Watson Pharmaceuticals, Inc., where he served as Manager of Corporate Development responsible for identifying, evaluating, closing and implementing strategic growth objectives; and initially he served as Senior Investor Relations Analyst responsible for developing communication strategies and directing interactions with Wall Street security analysts and institutional investors. Previously, Mr. Eso held several positions of increasing responsibility at various companies, including Allergan, Inc. and the Professional Golfers’ Association (PGA). Mr. Eso holds a bachelor’s degree in Communications, Public Relations from California State University, Fullerton and a master of Business Administration (MBA) from Concordia University, Irvine.

Teresa Berry is the Director of Facilities at Avid Bioservices. She has over twelve (12) years of experience in the industrial and commercial construction industry. In addition, she has over thirteen (13) years of experience with cGMP Facilities Operations in the biotechnology industry. Ms. Berry holds a Bachelor's degree in Health Sciences from California State University, Long Beach (CSULB). She is a Journeyman Inside Wireman with The International Brotherhood of Electrical Workers and is an active member of The International Society of Pharmaceutical Engineers. Prior to joining Avid Bioservices the Facilities Director worked for XOMA Corporation for nine years at their Santa Monica Pilot Plant in charge of the Facilities Operations. At Avid Bioservices, Ms. Berry is responsible for the preventative maintenance, calibrations, and repairs of all equipment and utilities, maintaining facility grounds and buildings, building construction and planning and the execution of those projects.

Gene heads the Manufacturing Department at Avid Bioservices which is responsible for all GMP cell banking, upstream, downstream, and filling processes. Gene has over 10 years of experience working in the biopharmaceutical industry with 8 years focused on GMP manufacturing. Prior to joining Avid Bioservices, Gene has worked at Peregrine Pharmaceuticals as a Research Associate and Manufacturing Manager, Amgen Incorporated as a Materials Associate, and IDEC Pharmaceuticals as a Cell Culture Technician. His hands-on experience with mammalian cell culture, monoclonal antibody purification, and Manufacturing Support Systems were developed while working in Quality Control, Manufacturing, Inventory Control and Process Development groups. Gene earned his B.S. in Biology at the University of California, Irvine in 1996.

John L. Quick has been associated with Peregrine and Avid since mid-2004 as a consultant on quality and regulatory compliance. He is founder of Quick & Associates a consulting firm devoted to quality, regulatory compliance and new product development consulting. Mr. Quick retired from Baxter International after a 37 year career with the company with responsibility for new product development and quality management . In 1998, Mr. Quick was appointed corporate vice president quality/regulatory compliance responsible for all worldwide quality and regulatory compliance at Baxter, reporting to the Chairman and CEO, a position he held until his retirement. Mr. Quick is immediate past Chairman of the Board of the Lincoln Foundation for Performance Excellence and is Vice Chairman of the Board of Methodist Hospital of Chicago and its parent corporation. Mr. Quick has an undergraduate degree in Chemistry from Indiana University and an MBA from the Northwestern J.L. Kellogg Graduate School of Management. He holds three issued patents and has made numerous industry presentations on the subject of quality and regulatory compliance.